Neurospan Editors

A thorough review raises questions about the effectiveness and safety of drugs targeting amyloid proteins in Alzheimer’s treatment.

Tarlatamab is a new option for improving survival rates in patients with difficult-to-treat small-cell lung cancer.

A recent study examines the obstacles faced by patients and caregivers in the Canadian healthcare system.

A large-scale study provides a detailed view of hippocampal changes from youth to old age.

Alzheimer’s disease pathology can influence the effectiveness of shunt procedures in patients with idiopathic normal pressure hydrocephalus.

New research examines the role of astrocytes in reducing Alzheimer’s-related brain plaques.

Advancements in diagnostics and treatment have reshaped our understanding of autoimmune myelitis in oncology.

New research examines the unfolding and refolding of prion proteins, providing insights into prion propagation mechanisms.

Research indicates that brain hyperperfusion may influence motor dysfunction in Parkinson’s patients, independently of dopamine depletion.

Mouse studies suggest ononin might boost cognitive function by improving neuronal activity and blood flow.